SARS-COV-2的不同变异:突变模式和致病性的综合综述

M. F. Khan, Fahmina Rizvi, M. Khan, W. A. Ansari, Kajim Ali, Mohd Aamish Khan
{"title":"SARS-COV-2的不同变异:突变模式和致病性的综合综述","authors":"M. F. Khan, Fahmina Rizvi, M. Khan, W. A. Ansari, Kajim Ali, Mohd Aamish Khan","doi":"10.2174/2666796704666230328171636","DOIUrl":null,"url":null,"abstract":"\n\nSevere acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a single-stranded and positive-sense RNA virus, is exhibiting a great degree of mutation acclimated to variable environments, posing a great threat to human life, with numerous SARS-CoV-2 variants. This review aims to analyze emerging strains of SARS-CoV-2, their mutational pattern, their impact on viral pathogenicity, and the identification of the targets for the development of vaccines and therapeutics against the virus. SARS-CoV-2 consists of four structural protein codes viz, peplomer protein (S), an envelope protein (E), nucleoprotein capsid (N), and matrix protein (M), that are involved in the ingression of the viral genome into the host cell by interacting with the host cell receptor, i.e., human angiotensin-converting enzyme 2 (ACE2) (only S protein is shown to bind to ACE-2 receptor). The review includes consequences of mutations- D614G (pre-dominant mutation), E484K, N501Y, K417N, L452R, P681H, del69/70, del157/158, Ins214EPE, and so forth, in alpha, beta, gamma, delta, omicron including other strains of SARS-CoV-2. Mutations include substitution, deletion, and insertion of amino acids in the spike glycoprotein of the SARS-CoV-2, resulting in antibody neutralization, immune escape, etc. As a consequence of modifications in the nucleotide sequence of the viral genome code pushed on by exposure to various environments, these new strains influence the pathogenicity of the virus.\n","PeriodicalId":10815,"journal":{"name":"Coronaviruses","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Different Variants of SARS-COV-2: A Comprehensive Review on Mutation Patterns and Pathogenicity\",\"authors\":\"M. F. Khan, Fahmina Rizvi, M. Khan, W. A. Ansari, Kajim Ali, Mohd Aamish Khan\",\"doi\":\"10.2174/2666796704666230328171636\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n\\nSevere acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a single-stranded and positive-sense RNA virus, is exhibiting a great degree of mutation acclimated to variable environments, posing a great threat to human life, with numerous SARS-CoV-2 variants. This review aims to analyze emerging strains of SARS-CoV-2, their mutational pattern, their impact on viral pathogenicity, and the identification of the targets for the development of vaccines and therapeutics against the virus. SARS-CoV-2 consists of four structural protein codes viz, peplomer protein (S), an envelope protein (E), nucleoprotein capsid (N), and matrix protein (M), that are involved in the ingression of the viral genome into the host cell by interacting with the host cell receptor, i.e., human angiotensin-converting enzyme 2 (ACE2) (only S protein is shown to bind to ACE-2 receptor). The review includes consequences of mutations- D614G (pre-dominant mutation), E484K, N501Y, K417N, L452R, P681H, del69/70, del157/158, Ins214EPE, and so forth, in alpha, beta, gamma, delta, omicron including other strains of SARS-CoV-2. Mutations include substitution, deletion, and insertion of amino acids in the spike glycoprotein of the SARS-CoV-2, resulting in antibody neutralization, immune escape, etc. As a consequence of modifications in the nucleotide sequence of the viral genome code pushed on by exposure to various environments, these new strains influence the pathogenicity of the virus.\\n\",\"PeriodicalId\":10815,\"journal\":{\"name\":\"Coronaviruses\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-03-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Coronaviruses\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/2666796704666230328171636\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Coronaviruses","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/2666796704666230328171636","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

严重急性呼吸综合征冠状病毒-2 (SARS-CoV-2)是一种单链正义RNA病毒,它正在表现出适应可变环境的高度突变,对人类生命构成巨大威胁,具有大量的SARS-CoV-2变体。本文旨在分析新出现的SARS-CoV-2毒株及其突变模式、对病毒致病性的影响,以及确定针对该病毒的疫苗和治疗方法的靶点。SARS-CoV-2由四种结构蛋白编码组成,即膜层蛋白(S)、包膜蛋白(E)、核蛋白衣壳(N)和基质蛋白(M),它们通过与宿主细胞受体(即人血管紧张素转换酶2 (ACE2))相互作用参与病毒基因组进入宿主细胞(只有S蛋白被显示与ACE-2受体结合)。该综述包括突变的后果- D614G(前显性突变)、E484K、N501Y、K417N、L452R、P681H、del69/70、del157/158、Ins214EPE等,包括其他SARS-CoV-2菌株的α、β、γ、δ、组粒。突变包括在SARS-CoV-2刺突糖蛋白中替换、缺失和插入氨基酸,导致抗体中和、免疫逃逸等。由于暴露在各种环境中,病毒基因组密码的核苷酸序列发生了改变,这些新毒株影响了病毒的致病性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Different Variants of SARS-COV-2: A Comprehensive Review on Mutation Patterns and Pathogenicity
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a single-stranded and positive-sense RNA virus, is exhibiting a great degree of mutation acclimated to variable environments, posing a great threat to human life, with numerous SARS-CoV-2 variants. This review aims to analyze emerging strains of SARS-CoV-2, their mutational pattern, their impact on viral pathogenicity, and the identification of the targets for the development of vaccines and therapeutics against the virus. SARS-CoV-2 consists of four structural protein codes viz, peplomer protein (S), an envelope protein (E), nucleoprotein capsid (N), and matrix protein (M), that are involved in the ingression of the viral genome into the host cell by interacting with the host cell receptor, i.e., human angiotensin-converting enzyme 2 (ACE2) (only S protein is shown to bind to ACE-2 receptor). The review includes consequences of mutations- D614G (pre-dominant mutation), E484K, N501Y, K417N, L452R, P681H, del69/70, del157/158, Ins214EPE, and so forth, in alpha, beta, gamma, delta, omicron including other strains of SARS-CoV-2. Mutations include substitution, deletion, and insertion of amino acids in the spike glycoprotein of the SARS-CoV-2, resulting in antibody neutralization, immune escape, etc. As a consequence of modifications in the nucleotide sequence of the viral genome code pushed on by exposure to various environments, these new strains influence the pathogenicity of the virus.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.50
自引率
0.00%
发文量
0
期刊最新文献
COVID-19 Vaccine Effectiveness on the Severity of Disease: A Case-control Study in Southeastern Iran Evaluation of Influenza Vaccination Coverage Among Healthcare Workers During the COVID-19 Pandemic and Analysis of Motivating and Hindering Factors Novel Coronavirus: An Overview of the History, Pathophysiology, Diagnosis, and Management of the Pandemic COVID-19 Catastrophe, with Special Emphasis on Herbal Treatment Alternatives Spectrum of Long COVID Symptoms and Management Approaches in Europe and Latin America Identification of Epitope Against Omicron Variant of SARS-CoV-2: In Silico Vaccine Design Approach
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1